Ariad制药的公告
内部交易: 2012-02-23,高级VP, Chief IP Officer,BERSTEIN DAVID L ,卖出,4100普通股, $15.00
内部交易: 2012-02-23,SVP, Corp. Dev. & Operations,DODION PIERRE F ,卖出,25000普通股, $15.00
内部交易: 2012-02-23,SVP, Corp. Dev. & Operations,DODION PIERRE F ,期权,25000普通股, $5.49
内部交易: 2012-02-21,高级VP, Chief IP Officer,BERSTEIN DAVID L ,卖出,35100普通股, $14.50
内部交易: 2012-02-21,高级VP, Chief IP Officer,BERSTEIN DAVID L ,期权,22800普通股, $3.90
内部交易: 2012-02-21,SVP, Clinical R&D, CMO,Haluska Frank ,卖出,4500普通股, $14.51
内部交易: 2012-02-21,SVP, Clinical R&D, CMO,Haluska Frank ,期权,4500普通股, $2.39
美东时间 2012-02-27 19:30 Q4 2011 ARIAD Pharmaceuticals, Inc. Earnings Conference Call
内部交易: 2012-02-14,SVP General Counsel & CCO,Keane Raymond T ,卖出,12500普通股, $15.13
内部交易: 2012-02-14,SVP General Counsel & CCO,Keane Raymond T ,期权,12500普通股, $1.30